Whether rheumatoid can be vaccinated with the New Crown Pneumonia vaccine depends on the stability of the disease, the patient’s physical condition and the type of vaccine. Rheumatoid rheumatism is not a contraindication to the New Crown Pneumonia vaccine, and rheumatoid patients can receive the New Crown Pneumonia vaccine if their condition is stable and they are in good physical condition; rheumatoid patients are advised to choose the inactivated New Crown vaccine and not the live attenuated New Crown vaccine. Even if you choose to receive the inactivated New Crown vaccine, rheumatoid patients still need to comply with the principle of vaccination when the disease is in a stable state and in good physical condition, i.e., in a safe state. When the disease is in an active stage, manifested by symptoms such as pressure pain and swelling on the joints, try not to receive the New Crown Pneumonia vaccine to avoid aggravating the disease. In addition, some patients will take considerable doses of glucocorticoids for treatment during rheumatism. In order not to affect the effect of the medicine during the treatment period, it is necessary to consider whether to reduce the dose or stop the medicine for 3 months before vaccination after consulting the attending doctor; some patients who may still need immunotherapy for the New Coronary Pneumonia vaccine will be vaccinated before or several months after the treatment, and it is still necessary to consult the attending doctor and local CDC.